BrightSpring Health Services, Inc. (BTSG) Earnings Call Analysis

NASDAQ · Healthcare · Health Information Services

24/25

Growth 5 Margin 5 Expansion 5 Platform 4 Financial 5

latest quarter score

Earnings Reports

24
BrightSpring (BTSG) Q2 2026: Provider Services Up 30% as Margin Expansion Accelerates
July 31, 2026
22
BTSG Q1 2026: Specialty Script Growth Surges 30% as Infusion and Operational Leverage Drive Margin Expansion
May 01, 2026
24
BrightSpring Health (BTSG) Q4 2025: EBITDA Jumps 41% as Specialty Pharmacy and Home Health Scale
February 27, 2026
24
BrightSpring Health (BTSG) Q3 2025: Specialty and Infusion Revenue Surges 42%, Margin Expansion Accelerates
October 29, 2025
20
BrightSpring Health (BTSG) Q2 2025: Specialty Scripts Jump 38% as LDD Pipeline Expands
August 01, 2025
25
BrightSpring (BTSG) Q1 2025: Pharmacy Solutions Revenue Jumps 28% as Specialty Pipeline Accelerates
July 06, 2025
25
BrightSpring Health Services (BTSG) Q4 2024: 29% Revenue Growth Accelerates Post-Divestiture Focus
March 06, 2025
BrightSpring Health (BTSG) Q3 2024: Specialty & Infusion Revenue Surges 42% as Pipeline Expands
November 01, 2024
BrightSpring Health Services (BTSG) Q2 2024: Specialty Pharmacy Drives 40% Growth, Margin Upside Signals Strong Second Half
August 02, 2024
BrightSpring Health (BTSG) Q1 2024: Specialty Pharmacy Surges 44%, Propelling Guidance Hike
May 02, 2024
BrightSpring (BTSG) Q4 2023: Pharmacy Revenue Jumps 30% as Integrated Care Drives Platform Expansion
February 29, 2024

Browse all companies